Kazi Nahar
Sydney Adventist Hospital(AU)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses, Colorectal Cancer Treatments and Studies, T-cell and B-cell Immunology
Most-Cited Works
- → Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy(2022)48 cited
- → Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab(2020)42 cited
- → Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report(2020)32 cited
- → Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis(2020)27 cited
- → Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor‐positive breast cancer(2017)16 cited
- → Safety and efficacy of anti-PD-1 antibodies in elderly patients with metastatic melanoma(2016)15 cited
- → Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis(2022)14 cited
- → Pathogenic PALB2 mutation in metastatic pancreatic adenocarcinoma and neuroendocrine tumour: A case report(2015)11 cited
- → Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series(2024)10 cited
- → Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma(2024)8 cited